Modular Bioactive Synthetic Bone Graft Technology (MST)

Researchers at Stanford have developed a biodegradable device and platform carrier of biologics for promoting faster bone healing of large bone defects, fractures, and non-union. This technology is designed, fabricated, and tested to meet multiple implementation criteria including: complex defect geometry, porosity, fabrication via 3D printing technology, biodegradation, growth factor delivery, and surgical implantation procedures. This invention is continued research of work disclosed in Stanford docket 20-447 "HyTEC:Hybrid Tissue Engineering Construct"

Stage of Development
Large animal studies